Fluctuations in serotonin transport may explain winter bluesSeptember 09, 2008Why do many Canadians get the winter blues? In the first study of its kind in the living human brain, Dr. Jeffrey Meyer and colleagues at the Centre for Addiction and Mental Health (CAMH) have discovered greater levels of serotonin transporter in the brain in winter than in summer. These findings have important implications for understanding seasonal mood change in healthy people, vulnerability to seasonal affective disorders and the relationship of light exposure to mood. CAMH's scientific team discovered that the serotonin transporter levels were significantly higher in all investigated brain regions in individuals studied in fall/winter, compared to those studied in spring/summer in a study of healthy subjects. Serotonin transporters remove serotonin so this discovery argues that there is more serotonin removal in the fall/winter as compared to spring/summer. Also, the higher serotonin transporter binding values occurred at times when there is less sunlight. This is the first time scientists have found differences in serotonin transporter levels in the brain in fall/winter versus spring/summer. Serotonin is involved in regulating physical functions such as eating and energy balance, and emotional functions like mood and energy levels. These phenomena vary across the seasons and the molecular background for why this happens was previously unknown. For this study, Dr. Jeffrey Meyer and his team used a world-leading positron emission tomography (PET) technology (originally created at CAMH by Dr. Alan Wilson) to detect these seasonal variations in serotonin transporter binding (the process that removes serotonin) in the living human brain and correlations between serotonin binding and duration of daily sunshine.
As Dr. Meyer explains, this is "an important lead in understanding how season changes serotonin levels. This offers an explanation for why some healthy people experience low mood and energy in the winter, and why there is a regular reoccurrence of depressive episodes in fall and winter in some vulnerable individuals. The next steps will be to understand what causes this change and how to interfere with it." According to the world health organization, major depressive disorder is the fourth leading cause of death and disability. Dr. Meyer points out that, "the future for treatment should be to prevent the illness itself." The presence of higher serotonin transporter levels might explain why many people experience the onset of major depressive episodes in the fall and winter. "Over the following years, we intend to determine the specifics of the environment (such as light exposure) that influence serotonin transporter levels so as to determine what is the optimal environment to prevent illness. In the future, it may be that just like we have lifestyle recommendations to prevent heart disease, we will have lifestyle recommendations to prevent major depressive disorder." Centre for Addiction and Mental Health | |||||||||||||||
|
Related Serotonin Transporter Current Events and Serotonin Transporter News Articles Genes determine whether sugar pills work It is a well-known fact in drug trials that individuals can respond just as well to placebos, sugar pills, as to the active drug. PET scans help identify mechanism underlying seasonal mood changes Brain scans taken at different times of year suggest that the actions of the serotonin transporter-involved in regulating the mood-altering neurotransmitter serotonin-vary by season, according to a report in the September issue of Archives of General Psychiatry, one of the JAMA/Archives journals. High anxiety? Right now, about half of all people who take medicine for an anxiety disorder don't get much help from it. And doctors have no definitive way to predict who will, and who won't, benefit from each anti-anxiety prescription they write. Sticky blood protein yields clues to autism Many children with autism have elevated blood levels of serotonin - a chemical with strong links to mood and anxiety. But what relevance this "hyperserotonemia" has for autism has remained a mystery. Finding may eventually help tailor treatment for depression When a treatment works for one person's depression, it does not always work for another person's. Findings from the University of Iowa may one day help doctors have a better idea of who will benefit from specific antidepressants, increasing the likelihood of successful treatment. Study reveals possible genetic risk for fetal alcohol disorders New research in primates suggests that infants and children who carry a certain gene variant may be more vulnerable to the ill effects of fetal alcohol exposure. Women more depressed and men more impulsive with reduced serotonin functioning Women and men appear to respond differently to the same biochemical manipulation. Major depressive disorder (MDD) is one of the most common mental disorders, and it is also one of the most studied. A pioneering study opens roads for tailor-made antidepressants In spite that the causes of depression have not still been fully identified, scientists acknowledge that genetic and environmental factors play a common role in the onset of this disorder. Gene linked with mental illness shapes brain region, researchers find A gene variant associated with mental illness goes hand-in-hand with enlargement of a brain region that handles negative emotions, researchers at UT Southwestern Medical Center and the Central Texas Veterans Health Care System have found. Forsyth scientists find linkages between serotonin reuptake inhibitors and bone mass Scientists at The Forsyth Institute have found that fluoxetine (Prozac), a drug used in the treatment of depression and obsessive-compulsive disorders, increases bone mass. More Serotonin Transporter Current Events and Serotonin Transporter News Articles |
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||